Australia markets close in 54 minutes

Tonix Pharmaceuticals Holding Corp. (TNXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6985-0.0388 (-5.26%)
At close: 04:00PM EDT
0.4987 -0.20 (-28.60%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.41M
Enterprise value -11.94M
Trailing P/E 0.29
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.09
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.10

Trading information

Stock price history

Beta (5Y monthly) 2.21
52-week change 3-77.66%
S&P500 52-week change 319.21%
52-week high 39.8125
52-week low 30.6801
50-day moving average 31.0388
200-day moving average 32.9112

Share statistics

Avg vol (3-month) 3404.04k
Avg vol (10-day) 3201.94k
Shares outstanding 517.76M
Implied shares outstanding 617.76M
Float 817.76M
% held by insiders 10.04%
% held by institutions 111.94%
Shares short (14 Sept 2023) 4105.5k
Short ratio (14 Sept 2023) 40.57
Short % of float (14 Sept 2023) 40.59%
Short % of shares outstanding (14 Sept 2023) 40.59%
Shares short (prior month 14 Aug 2023) 4458.19k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 331 Oct 2019
Ex-dividend date 4N/A
Last split factor 216:100
Last split date 309 May 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 June 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-35.91%
Return on equity (ttm)-60.97%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -122.32M
Net income avi to common (ttm)-124.43M
Diluted EPS (ttm)-8.5600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)25.62M
Total cash per share (mrq)1.44
Total debt (mrq)1.27M
Total debt/equity (mrq)0.90%
Current ratio (mrq)2.78
Book value per share (mrq)13.05

Cash flow statement

Operating cash flow (ttm)-102.11M
Levered free cash flow (ttm)-60.62M